ACNU Rule Gets Review As Trump’s ‘Regulatory Freeze’ Delays Effective Date Two Months

Critics of requirements that sponsors first demonstrate conventional labeling wouldn’t support an OTC switch before submitting proposals for ACNU switches and for simultaneous availability of Rx formulations of approved ACNU switches likely look to delay as chance to convince the agency to strike one or both components of the final rule.